In response Notice of Special Interest: Clinical and Translational Science Award (CTSA) Program Administrative Supplements (NOT-TR-20-014), the Georgia CTSA proposes to create a dedicated quality assurance/quality control position to perform quality reviews of CTSA-related submissions to NCATS, submissions to the eRA Human Subjects System, and management of the overall process.

Public Health Relevance

The CTSA Program supports a national consortium of medical research institutions that work together to tackle system-wide scientific and operational changes that solve the many outstanding problems limiting the efficiency, effectiveness, and reach of clinical translational research, and thus get more treatments to more patients more quickly across the country. Towards the effort of focusing on widely appreciated systematic barriers, the Georgia CTSA proposes to add a dedicated quality assurance/quality control position to perform quality reviews of Georgia CTSA-related submissions to NCATS, submissions to the eRA Human Subjects System, and management of the overall process.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR002378-04S1
Application #
10158624
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Davis Nagel, Joan
Project Start
2017-09-22
Project End
2022-06-30
Budget Start
2020-07-08
Budget End
2021-06-30
Support Year
4
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Emory University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Brust, James C M; Shah, N Sarita; Mlisana, Koleka et al. (2018) Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South Africa. Clin Infect Dis 66:1246-1253
Wang, Jiaxing; Li, Ying; King, Rebecca et al. (2018) Optic nerve regeneration in the mouse is a complex trait modulated by genetic background. Mol Vis 24:174-186
IeDEA and COHERE Cohort Collaborations (2018) Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs. Clin Infect Dis 66:893-903
Umpierrez, Guillermo E; Cardona, Saumeth; Chachkhiani, David et al. (2018) A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial. J Am Med Dir Assoc 19:399-404.e3
Guercio, Cailey; Mehta, Akanksha (2018) Predictors of Patient and Partner Satisfaction Following Radical Prostatectomy. Sex Med Rev 6:295-301
Umpierrez, Guillermo E; Klonoff, David C (2018) Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 41:1579-1589
Reaves, Barbara J; Wallis, Connor; McCoy, Ciaran J et al. (2018) Recognition and killing of Brugia malayi microfilariae by human immune cells is dependent on the parasite sample and is not altered by ivermectin treatment. Int J Parasitol Drugs Drug Resist 8:587-595
Wang, Tiffany; Kraft, Colleen S; Woodworth, Michael H et al. (2018) Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections. Open Forum Infect Dis 5:ofy016
Martin, Greg S (2018) The Medical Perspective on a Disease Life Cycle. Sepsis in the Realm of Implementation Science. Am J Respir Crit Care Med 198:1360-1361
Serota, David P; Sexton, Mary Elizabeth; Kraft, Colleen S et al. (2018) Severe Community-Acquired Pneumonia due to Acinetobacter baumannii in North America: Case Report and Review of the Literature. Open Forum Infect Dis 5:ofy044

Showing the most recent 10 out of 87 publications